ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Renal Pharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1573469
Deciphering Cellular Heterogeneity and Pathway Dynamics in Urinary Samples: A UMAP-Based Approach to Understanding Acute Kidney Injury
Provisionally accepted
- 1Yichang Central People's Hospital, Yichang, Hubei Province, China
- 2Wuhan First Hospital, Wuhan, Hebei Province, China
- 3Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Acute kidney injury (AKI) is characterized by rapid loss of renal function and is associated with severe clinical outcomes. Understanding the cellular heterogeneity in urine samples during AKI may provide insights into the underlying pathophysiological mechanisms and potential therapeutic targets. Objectives: To explore the cellular composition and gene expression patterns in urine samples from AKI and non-AKI conditions using Uniform Manifold Approximation and Projection (UMAP) to identify key cellular interactions and pathway activations related to AKI. Methods: We utilized publicly available the dataset GSE180595 from the Gene Expression Omnibus (GEO) database.Urine samples were collected from AKI and non-AKI patients. Single-cell RNA sequencing (scRNA-seq) was performed to profile the mononuclear cell populations. Differential gene expression analysis was conducted to identify key molecular pathways, with a focus on ECM-related pathways. MAPK1 expression was quantified and compared between the two patient groups. Results: UMAP analysis revealed significant differences in cellular composition between AKI and non-AKI samples. Fifteen unique cell clusters were identified, each associated with distinct transcriptional profiles. In AKI samples, increased clustering of immune response cells such as monocytes was observed. Pathway analysis highlighted enhanced activation of DNA replication and ECM-related genes pathways in cells from AKI conditions, indicating their potential roles in injury response and tissue remodeling.The differential gene enrichment analysis identified ECM-related pathways as significantly enriched in the AKI group, with MAPK1 being a crucial gene regulating these pathways. Conclusions: Our findings provide evidence that MAPK1 is upregulated in urinary mononuclear cells of AKI patients and plays a key role in regulating ECM-related pathways. MAPK1 could serve as a potential biomarker for AKI diagnosis and prognosis and may represent a promising therapeutic target for limiting ECM remodeling and fibrosis in AKI. Further studies are needed to explore the clinical implications of targeting MAPK1 in AKI treatment.
Keywords: acute kidney injury (AKI), MAPK1 (ERK1/2), single-cell RNA sequencing (scRNA-seq), Urinary biomarkers, monocyte
Received: 11 Feb 2025; Accepted: 28 Jul 2025.
Copyright: © 2025 Yuan, Wu, Xiang and Ni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Cheng Yuan, Yichang Central People's Hospital, Yichang, Hubei Province, China
Lihua Ni, Zhongnan Hospital, Wuhan University, Wuhan, 430071, Hubei Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.